Descriptives of the study sample, N = 451. by Orrin D. Ware (14829115)

Participants characteristics. by Sakiko Fukui (387048)

“…Cluster analysis classified 4 clusters of decline in food intake changes during the last 6 months before death: immediate decrease (n = 14); decrease from 1 month before death (n = 24); decrease from 3 months before death (n = 7); and gradual decrease for 6 months before death (n = 24).…”

A flow diagram of the study entry. by Sakiko Fukui (387048)

“…Cluster analysis classified 4 clusters of decline in food intake changes during the last 6 months before death: immediate decrease (n = 14); decrease from 1 month before death (n = 24); decrease from 3 months before death (n = 7); and gradual decrease for 6 months before death (n = 24).…”

Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

Overview of the six original ACTIV-3/TICO trials. by Elizabeth S. Munroe (21568166)

“…We pooled results from four trials of anti-spike nMAbs. …”

Significant Decrease in Vessel Count of Trade Vessels in (a) Bosporus Strait and (b) Bab el-Mandeb Strait. by Cherryl Chico (20978829)

Baseline data of each group (mean±standard deviation)/n (%)/(M(IQR)). by Na Wang (193263)

Mean observer DCCR (%) and DDR (%) at C2-3 in neutral (n = 22) and flexed (n = 18) neck positions. by Devon England (21262225)

Relevant follow-up evaluation indicators after operation (mean±standard deviation)/n (%). by Na Wang (193263)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

Skin marks is the S1 Fig title. by Mercedes Soto-González (20422078)

“…</p><p>Results</p><p>The IRD decreased after both exercise programs compared to baseline measurements in AB2 (mean difference: 3.06 mm, 95% CI: 1.06 to 5.05) and in AB5 (mean difference: 2.88 mm, 95% CI: 1.59 to 4.17), confirming the long-term effect of exercise. …”

The mean and standard deviation of outcome measures. by Soheila Qanbari (20455173)

<b>When more isn’t better: Sperm competition decreases fertilization success and motile sperm in two sea urchin species</b> by Luisa Kumpitsch (20874095)

Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies. by Elizabeth S. Munroe (21568166)

Characteristics of patients with acute aortic dissection (n = 538). by Ayami Ishikawa (19838027)

Boxplot comparing Ct values for HD in flies and clothes. by Philippe Ndzomo (17706039)

Mean observer DCCR (%) and DDR (%) at C3-4 in neutral and flexed neck positions in horses that were not operated (n = 18) versus were operated (n = 4) at this site. by Devon England (21262225)